Global Branded Generics Market - PowerPoint PPT Presentation

About This Presentation
Title:

Global Branded Generics Market

Description:

Global Branded Generics Market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026 – PowerPoint PPT presentation

Number of Views:22
Slides: 7
Provided by: nileshdbmr
Category:

less

Transcript and Presenter's Notes

Title: Global Branded Generics Market


1
Global Branded Generics Market Industry Trends
- Forecast to 2026
Global Branded Generics Market By Product Type
(Value-Added Branded Generics, Trade Named
Generics), Therapeutic Application (Oncology,
Cardiovascular Diseases, Diabetes, Neurology,
Gastrointestinal Diseases, Dermatology Diseases,
Analgesics Anti-Inflammatory, Others), Drug
Class (Alkylating Agents, Antimetabolites,
Hormones, Anti-Hypertensive, Lipid Lowering
Drugs, Anti-Depressants, Anti-Psychotics,
Anti-Epileptic, Others), Consumption Type (Oral,
Parenteral, Topical, Others), Distribution
Channel (Hospital Pharmacies, Retail Pharmacies,
Online Pharmacies, Others), 
Browse Full Report and Details TOC
https//www.databridgemarketresearch.com/toc/?dbm
rglobal-branded-generics-market
2
Report Description
Global Branded Generics Market is expected to
rise from its initial estimated value of USD
232.83 billion in 2018 to a projected value of
USD 421.15 billion by 2026, registering a CAGR of
7.69 in the forecast period of 2019-2026.
Branded generic can be defined as those
pharmaceutical drugs that have been re-released
with a different brand name. These drugs are
produced by various pharmaceutical manufacturing
companies as the patent of this drug has already
expired and the generic drugs are sold at a lower
cost. Even though, there isnt any difference in
the quality or manufacturing process of the
drug.
3
Major Key Players
  • Some of the major players operating in this
    market are
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Cadila
  • Hetero
  • AstraZeneca
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Aspen Holdings
  • Bausch Health

Inquire Before Buying https//www.databridgemark
etresearch.com/inquire-before-buying/?dbmrglobal-
branded-generics-market
4
Market Segmentation
  • By Product Type (Value-Added Branded Generics,
    Trade Named Generics)
  • By Therapeutic Application (Oncology,
    Cardiovascular Diseases, Diabetes, Neurology,
    Gastrointestinal Diseases, Dermatology Diseases,
    Analgesics Anti-Inflammatory, Others)
  • By Drug Class (Alkylating Agents,
    Antimetabolites, Hormones, Anti-Hypertensive,
    Lipid Lowering Drugs, Anti-Depressants,
    Anti-Psychotics, Anti-Epileptic, Others)
  • By Consumption Type (Oral, Parenteral, Topical,
    Others)

Get Exclusive Sample Report _at_ https//www.databri
dgemarketresearch.com/request-a-sample/?dbmrgloba
l-branded-generics-market
5
Regional Analysis
  • Based on geography, the market is segmented into
    five geographical regions
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East
  • Africa

6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com